Christian Schneider

Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.

Engages in manufacturing of products

Develops and commercializes tools for use in the focal ablation of soft tissues

PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields.

Manufactures healthcare products

Develops innovative medicines, treatments and diagnostics

Develops and markets biological diagnostic products